These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11179062)

  • 1. Prevention of ischemic ventricular tachycardia of Purkinje origin: role for alpha(2)-adrenoceptors in Purkinje?
    Arnar DO; Xing D; Lee H; Martins JB
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1182-90. PubMed ID: 11179062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor.
    Gopinathannair R; Chaudhary AK; Xing D; Ely D; Zheng W; Martins JB
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1889-98. PubMed ID: 19783782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-2 adrenergic antagonism enhances risk of ventricular tachycardia during acute ischemia.
    Arnar DO; Xing D; Martins JB
    Scand Cardiovasc J; 2007 Dec; 41(6):378-85. PubMed ID: 17852790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Purkinje system in spontaneous ventricular tachycardia during acute ischemia in a canine model.
    Arnar DO; Bullinga JR; Martins JB
    Circulation; 1997 Oct; 96(7):2421-9. PubMed ID: 9337219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggered activity due to delayed afterdepolarizations in sites of focal origin of ischemic ventricular tachycardia.
    Xing D; Martins JB
    Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2078-84. PubMed ID: 15475531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical scavenger specifically prevents ischemic focal ventricular tachycardia.
    Xing D; Chaudhary AK; Miller FJ; Martins JB
    Heart Rhythm; 2009 Apr; 6(4):530-6. PubMed ID: 19324315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-Adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo.
    Cai JJ; Morgan DA; Haynes WG; Martins JB; Lee HC
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2606-11. PubMed ID: 12427600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purkinje involvement in arrhythmias after coronary artery reperfusion.
    Arnar DO; Martins JB
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1189-96. PubMed ID: 11893551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.
    Pogwizd SM
    Circulation; 1994 Sep; 90(3):1441-58. PubMed ID: 7522134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to Purkinje-Related Monomorphic Ventricular Tachycardia After Ablation of Ventricular Fibrillation in Ischemic Heart Disease.
    Masuda K; Nogami A; Kuroki K; Igarashi M; Sekiguchi Y; Komatsu Y; Kowase S; Kurosaki K; Nishihara S; Niwa K; Tsuchiya T; Igawa M; Aonuma K
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs.
    Xing D; Kjølbye AL; Nielsen MS; Petersen JS; Harlow KW; Holstein-Rathlou NH; Martins JB
    J Cardiovasc Electrophysiol; 2003 May; 14(5):510-20. PubMed ID: 12776869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model.
    Issa ZF; Ujhelyi MR; Hildebrand KR; Zhou X; Rosenberger J; Groh WJ; Miller JM; Zipes DP
    Heart Rhythm; 2005 Oct; 2(10):1122-7. PubMed ID: 16188594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs.
    Xing D; Kjølbye AL; Petersen JS; Martins JB
    Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H511-6. PubMed ID: 15650154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular electrophysiologic characteristics of surviving subendocardial fibers in chronically infarcted right ventricular myocardium susceptible to inducible sustained ventricular tachycardia.
    Sugi K; Karagueuzian HS; Fishbein MC; Mandel WJ; Peter T
    Am Heart J; 1987 Sep; 114(3):559-69. PubMed ID: 3630897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Purkinje fibers in post-infarction ventricular tachycardia.
    Bogun F; Good E; Reich S; Elmouchi D; Igic P; Tschopp D; Dey S; Wimmer A; Jongnarangsin K; Oral H; Chugh A; Pelosi F; Morady F
    J Am Coll Cardiol; 2006 Dec; 48(12):2500-7. PubMed ID: 17174189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers.
    Hayashi M; Kobayashi Y; Iwasaki YK; Morita N; Miyauchi Y; Kato T; Takano T
    Heart Rhythm; 2006 Aug; 3(8):908-18. PubMed ID: 16876739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia.
    Martins JB; Chaudhary AK; Jiang S; Kwofie M; Mackie P; Miller FJ
    Int J Mol Sci; 2014 Nov; 15(11):20079-100. PubMed ID: 25375191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and reflex sympathetic control of transmural activation and rate of ventricular tachycardia in ischemic and hypertrophic ventricular myocardium of the dog.
    Hopson JR; Martins JB
    Circulation; 1992 Aug; 86(2):618-27. PubMed ID: 1353421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal initiation of sustained and nonsustained ventricular tachycardia in a canine model of ischemic cardiomyopathy.
    Johnson CM; Pogwizd SM
    J Cardiovasc Electrophysiol; 2012 May; 23(5):543-52. PubMed ID: 22175759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular tachycardia ablation in patients with coronary heart disease: beyond the reentry circuit.
    Cavaco D; Adragão P; Morgado F; Reis-Santos K; Vieira AP; Chotalal D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 2005 May; 24(5):715-21. PubMed ID: 16041967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.